Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Combined Effects of Drugs: Synergism

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...

Antimicrobial Effectiveness

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...

Antibiotic Selection

Antibiotic Selection

Development of Antibiotic Resistance

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...

Inhibitors of Bacterial Protein Synthesis

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The latest updates on the proper use of fluoroquinolones - Actualisation 2025 update by the SPILF and the GPIP.

Infectious diseases now·2025

Same author

SPILF update on bacterial arthritis in adults and children.

Infectious diseases now·2023

Same author

Utilization of macrolides. State of the art 2022 Spilf and GPIP.

Infectious diseases now·2022

Same author

Anti-infectious treatment duration: The SPILF and GPIP French guidelines and recommendations.

Infectious diseases now·2021

Same author

Home intravenous antibiotherapy and the proper use of elastomeric pumps: Systematic review of the literature and proposals for improved use.

Infectious diseases now·2021

Same author

Erratum to "Diamantis S, Longuet P, Lesprit P, Gauzit R. Terms of use of outpatient parenteral antibiotic therapy" Med Mal Infect. 2020 Jun 20:S0399-077X(20)30153-0. doi: 10.1016/j.medmal.2020.06.004.

Infectious diseases now·2020

Search research articles

Related Experiment Video

Updated: May 23, 2026

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

Generic antibiotic drugs: is effectiveness guaranteed?

R Gauzit¹, M Lakdhari

¹Unité de réanimation, Hôtel Dieu, place du Parvis-de-Notre-Dame, Paris cedex 04, France. remy.gauzit@htd.aphp.fr

Medecine Et Maladies Infectieuses

|April 7, 2012

Summary

Generic antibiotic drugs may not be therapeutically equivalent to branded ones, especially intravenous formulations. Differences in components, impurities, and effectiveness necessitate a review of marketing authorization regulations for generic antibiotics.

More Related Videos

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

Related Experiment Videos

Last Updated: May 23, 2026

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

Area of Science:

Pharmacology
Drug Regulation
Microbiology

Background:

Concerns exist regarding the therapeutic equivalence of generic versus branded antibiotic drugs.
Generic intravenous antibiotics bypass bioequivalence studies, raising reliability questions.
Variability in generic antibiotic quality, including components and impurities, impacts effectiveness.

Purpose of the Study:

To evaluate the reliability and therapeutic equivalence of generic antibiotic drugs compared to their branded counterparts.
To investigate the dispersion of results in generic antibiotic drug effectiveness.
To examine the impact of generic antibiotic marketing on antibiotic resistance.

Main Methods:

Review of existing literature and published arguments on generic antibiotic drug reliability.
Analysis of data on generic antibiotic components, impurities, pharmacokinetics, and in vitro/in vivo effectiveness.
Examination of clinical effectiveness data and post-marketing surveillance.

Main Results:

Significant dispersion in effectiveness results among generic antibiotics, even for the same agent.
Identified differences in drug components, impurities, pharmacokinetics, and pharmacodynamics.
Increased antibiotic use and resistance, particularly with oral fluoroquinolones, following generic drug marketing.

Conclusions:

Generic antibiotic drugs may not consistently meet the specifications of branded drugs.
Current regulations for marketing authorization of generic antibiotics may require revision.
Further verification of available data and clinical effectiveness studies are needed.